| Product NDC: | 68047-254 |
| Proprietary Name: | OSCIMIN |
| Non Proprietary Name: | Hyoscyamine Sulfate |
| Active Ingredient(s): | .125 mg/1 & nbsp; Hyoscyamine Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68047-254 |
| Labeler Name: | Larken Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20110803 |
| Package NDC: | 68047-254-01 |
| Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68047-254-01) |
| NDC Code | 68047-254-01 |
| Proprietary Name | OSCIMIN |
| Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68047-254-01) |
| Product NDC | 68047-254 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hyoscyamine Sulfate |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20110803 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Larken Laboratories, Inc. |
| Substance Name | HYOSCYAMINE SULFATE |
| Strength Number | .125 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |